Lorazepam (A�van)
 Lorazepam may substitute midazolam during midazolam shortages

ACTION:  Seda�ve, An�-Seizure
•

Lorazepam is a potent, short-ac�ng benzodiazepine with seda�ve eﬀects. It has no eﬀect on pain.

INDICATIONS:
•  Premedica�on before cardioversion, external pacing and other painful procedures.
•  Seizures (status epilep�cus).
•  Agitated pa�ent who may be a danger to self or others.

CONTRAINDICATIONS:
•  Hypersensi�vity   • Shock, with depressed vital signs
•  Narrow-angle glaucoma  • Alcoholic coma

POTENTIAL SIDE EFFECTS:
Laryngospasm   • AMS
•
•  Bronchospasm   • Bradycardia
•  Dyspnea
•  Respiratory depression and arrest
•  Drowsiness
•  Amnesia  • Vomi�ng

ADULT DOSE/ROUTE:
⇒ Seda�on/Agita�on: 2mg slow push IV/IO or IM.
⇒ Seizure: 4 mg IM x1 or intranasally (2mg each nostril) or 4mg slow push IV/IO. Maximum total dose 4

mg IM/IV/IO.

PEDIATRIC DOSE/ROUTE:
⇒ Seda�on/Agita�on: 0.05 mg/kg IM/IV/IO slow push.  Maximum total dose 2 mg IM/IV/IO.
⇒ Seizure: 0.1 mg/kg IM/IV/IO x1 (Max 4mg) or intranasally (half in each nostril. Maximum total dose

4mg).

NOTES:
•  Contact Base Hospital if seizure ac�vity or agita�on con�nues a�er maximum dose is reached and

addi�onal doses may be required.

•  Do not use intranasal route in agita�on because amount of absorp�on in an ac�vely resis�ng,

agitated pa�ents is unknown.

•  Eﬀects of lorazepam may be poten�ated if administered with opiate pain medica�ons. Contact Base

•

•

Hospital if considering administering both medica�ons.
Lorazepam clinical eﬀects may take 20-30 minutes when given IM. Use cau�on to prevent
medica�on stacking and wait 20 minutes between doses.
Lorazepam is more viscous (thicker) than other medica�ons and may require more eﬀort to draw up
and administer, especially intranasally.

•

Lorazepam needs to be refrigerated during storage. Once removed from refrigera�on, it has a shelf
life of 60 days in temperature stable environments (including vehicles). Vials should not be re-
refrigerated a�er being removed.

•  Always be prepared to protect airway and ven�late pa�ents who are given benzodiazepines.
Con�nuous monitoring of vital signs before and a�er administra�on is required. End-�dal CO2
should be monitored a�er administra�on to monitor for respiratory depression.

Eﬀective: 04/01/2024
Supersedes: 09/22/2023

